Focal Epilepsy ráðstevna.jpg
Skriva út

Ráðstevna um Epilepsi

mikudagur 24.05.2017, kl. 10:38, Hotel Føroyar

Í døgunum 24. til 27. maj verður stór altjóða ráðstevna í Føroyum um epilepsi.

Ráðstevnan kallast Focal Epilepsy Conference 2017 Faroe Islands og verður fyriskipað av Danish Epilepsy Center, Filadelfia og Amplexa Genetics A/S við hjálp frá VisitFaroeIslands.

20 granskarar úr øllum heiminum halda fyrilestrar. Postarar verða lagdir fram og annað verður eisini á skánni.

Les meira um skrá,  tilmelding og uppskot til postarar her

Endamálið við ráðstevnuni

The aim of the conference is to bring together researchers and clinicians working with focal epilepsies to present the latest knowledge in the genetic aetiology of focal epilepsy along with phenotypic and diagnostic aspects of the disorder. The target audience for the meeting is clinicians, epileptologists, neurologists and paediatrics interested in focal epilepsies.

The program will cover clinical aspects, geno-phenotype correlation, genetic aetiology and treatment options in relation to the known molecular mechanisms.

Two general overview lectures will be given. The aim of these is to give a basic oveview of genetic and clinical aspects of focal epielpsies by prof. Ingo Helbig and an overview on clinical phenotype and genetics of brainmalformation in focal epieplesies by prof. Renzo Guerrini. 

Surgery as treatment option will be covered and lessons from functional studies and models organisms will be presented.We wil get novel results from one of the latest large scale research studies and finally the prospects of precsion medicine in focal epilepsy will be highlighted.

Vísindaliga nevndin fyri ráðstevnuna

Johannes Lemke, Prof. University of Leipzig
Guido Rubboli, Prof. University of Copenhagen and Danish Epilpesy Centre
Helle Hjalgrim, Assoc. Prof. of Southern Denmark and Danish Epilepsy Centre
Rikke Møller, Assoc. Prof. University of Denmark and Danish Epilepsy Centre
Leanne Dibbens, Assoc. Prof. University of South Australia, Adeleide
Hans Atli Dahl, Ph.D. and CEO, Amplexa Genetics A/S